Pressure BioSciences Inc (OTCMKTS:PBIO) Stock Gains Momentum: Here is Why

The biotech sector has been one of the more popular sectors for investors in recent years and every other day there are companies that come up with a wider range of innovative solutions for various healthcare issues.

One of the companies that ought to be followed by investors at this point in time is Pressure BioSciences Inc (OTCMKTS:PBIO), which can lay claim to being among the more innovative companies in its sector at this point. The company is involved in the sales and development of advanced pressure-based solutions meant to complement the global life sciences industry. In this regard, it ought to be noted that the company’s pressure-based solutions are deployed in other industries as well.

Discusses the Significant 2022 Revenue Potential of Its Innovative and Enabling Ultra Shear Technology Platform with The Stock Day Podcast

The secret sauce at Pressure BioSciences is the pressure cycling technology or PCT, which the company has already patented. At this point in time, Pressure BioSciences is primarily involved in developing a range of products that are powered by pressure cycling technology and then offering it to different industries, including medicine development and discovery.

Now that you have a fair idea about the sort of work that the company is involved in, it may now be a good time to look into some of the recent development in order to have a fairer idea about the stock.

Yesterday, the company came into considerable focus after Richard T Schumacher, its Chief Executive Officer and President made an appearance on The Stock Day Podcast, which remains one of the more popular podcasts related to the stock market at this point. The podcast is hosted by Everett Jolly. At the podcast interview, Schumacher spoke about the three pressure-based technology platforms that the company has managed to come up with.

In addition to that, he went on to elaborate on the fact that the platforms could be put to use in a wide range of industries. More importantly, he went on to state that Pressure BioSciences expected its revenues to rise significantly in 2022 owing to the possibilities of its Ultra Shear Technology Platform. It may be a good time to start tracking the stock.

Leave a Reply

Your email address will not be published.